Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 3, 2004; DOI: 10.1124/jpet.104.076588
0022-3565/05/3123-1043-1054$20.00
JPET 312:1043-1054, 2005
CELLULAR AND MOLECULAR
Angiotensin II-Induced Akt Activation through the Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells Is Mediated by Phospholipid Metabolites Derived by Activation of Phospholipase D
Fang Li, and
Kafait U. Malik
Department of Pharmacology and Vascular Biology Center of Excellence, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
Angiotensin II (Ang II) activates cytosolic Ca2+-dependent phospholipase A2 (cPLA2), phospholipase D (PLD), p38 mitogen-activated protein kinase (MAPK), epidermal growth factor receptor (EGFR) and Akt in vascular smooth muscle cells (VSMC). This study was conducted to investigate the relationship between Akt activation by Ang II and other signaling molecules in rat VSMC. Ang II-induced Akt phosphorylation was significantly reduced by the PLD inhibitor 1-butanol, but not by its inactive analog 2-butanol, and by brefeldin A, an inhibitor of the PLD cofactor ADP-ribosylation factor, and in cells infected with retrovirus containing PLD2 siRNA or transfected with PLD2 antisense but not control LacZ or sense oligonucleotide. Diacylglycerol kinase inhibitor II diminished Ang II-induced and diC8-phosphatidic acid (PA)-increased Akt phosphorylation, suggesting that PLD-dependent Akt activation is mediated by PA. Ang II-induced EGFR phosphorylation was inhibited by 1-butanol and PLD2 siRNA and also by cPLA2 siRNA. In addition, the inhibitor of arachidonic acid (AA) metabolism 5,8,11,14-eicosatetraynoic acid (ETYA) reduced both Ang II- and AA-induced EGFR transactivation. Furthermore, ETYA, cPLA2 antisense, and cPLA2 siRNA attenuated Ang II-elicited PLD activation. p38 MAPK inhibitor SB202190 [4-(4-flurophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] reduced PLD activity and EGFR and Akt phosphorylation elicited by Ang II. Pyrrolidine-1, a cPLA2 inhibitor, and cPLA2 siRNA decreased p38 MAPK activity. These data indicate that Ang II-stimulated Akt activity is mediated by cPLA2-dependent, p38 MAPK regulated PLD2 activation and EGFR transactivation. We propose the following scheme of the sequence of events leading to activation of Akt in VSMC by Ang II: Ang II
cPLA2
AA
p38 MAPK
PLD2
PA
EGFR
Akt.
Received August 23, 2004;
accepted October 29, 2004.
Address correspondence to: Dr. Kafait U. Malik, Professor of Pharmacology, Department of Pharmacology, College of Medicine, University of Tennessee Health Science Center, Room 115, Crowe Building, 874 Union Avenue, Memphis, TN 38163. E-mail: kmalik{at}utmem.edu
This article has been cited by other articles:

|
 |

|
 |
 
S. J. Assinder, Q. Dong, H. Mangs, and D. R. Richardson
Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-{beta} Pathways in Prostate Cancer
Mol. Pharmacol.,
March 1, 2009;
75(3):
429 - 436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Lee, T. Palaia, and L. Ragolia
Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation
Am J Physiol Cell Physiol,
February 1, 2009;
296(2):
C327 - C338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. Kim, J.-Y. Byun, C.-H. Yun, I.-C. Park, K.-H. Lee, and S.-J. Lee
c-Src-p38 Mitogen-Activated Protein Kinase Signaling Is Required for Akt Activation in Response to Ionizing Radiation
Mol. Cancer Res.,
December 1, 2008;
6(12):
1872 - 1880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Block and J. K. Klarlund
Wounding Sheets of Epithelial Cells Activates the Epidermal Growth Factor Receptor through Distinct Short- and Long-Range Mechanisms
Mol. Biol. Cell,
November 1, 2008;
19(11):
4909 - 4917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Knoepp, M. S. Chahal, Y. Xie, Z. Zhang, D. J. Brauner, M. A. Hallman, S. A. Robinson, S. Han, M. Imai, S. Tomlinson, et al.
Effects of Active and Inactive Phospholipase D2 on Signal Transduction, Adhesion, Migration, Invasion, and Metastasis in EL4 Lymphoma Cells
Mol. Pharmacol.,
September 1, 2008;
74(3):
574 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Yaghini, F. Li, and K. U. Malik
Expression and Mechanism of Spleen Tyrosine Kinase Activation by Angiotensin II and Its Implication in Protein Synthesis in Rat Vascular Smooth Muscle Cells
J. Biol. Chem.,
June 8, 2007;
282(23):
16878 - 16890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Lee and L. Ragolia
AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells
Am J Physiol Cell Physiol,
December 1, 2006;
291(6):
C1355 - C1365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lee, H.-K. Lim, J. Sakong, Y.-S. Lee, J.-R. Kim, and S.-H. Baek
Janus Kinase-Signal Transducer and Activator of Transcription Mediates Phosphatidic Acid-Induced Interleukin (IL)-1beta and IL-6 Production
Mol. Pharmacol.,
March 1, 2006;
69(3):
1041 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Li, C. Zhang, S. Schaefer, A. Estes, and K. U. Malik
ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery
Am J Physiol Heart Circ Physiol,
December 1, 2005;
289(6):
H2592 - H2601.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.